Macrophage-secreted factors enhance the in vitro expansion of DMD muscle precursor cells while preserving their myogenic potential

Neurological Research

Volumn 32, Issue 1, 2010, Pages 55-62

  Malerba, Alberto ^a,b   Pasut, Alessandra ^a   Frigo, Marco ^a   De Coppi, Paolo ^a,b   Baroni, M David ^a   Vitiello, Libero ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Duchenne muscular dystrophy; Macrophagic factors; Muscle precursor cells; Myoblast transfer therapy

Indexed keywords

BETA GALACTOSIDASE; DESMIN; MYOD PROTEIN; TELOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; MUSCLE STEM CELL; NONHUMAN; STEM CELL; STEM CELL EXPANSION;

ANIMALS; CELL COUNT; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DYSTROPHIN; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MACROPHAGES; MICE; MICE, NUDE; MUSCLE CELLS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; TELOMERASE; TIME FACTORS;

EID: 77949436939     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X380865     Document Type: Article

References (26)

1. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: One gene, several proteins, multiple phenotypes. Lancet Neurol 2003; 2: 731-740
2. Kapsa R, Kornberg AJ, Byrne E. Novel therapies for Duchenne muscular dystrophy. Lancet Neurol 2003; 2: 299-310
3. Peault B, Rudnicki M, Torrente Y, et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007; 15: 867-877
4. Gussoni E, Soneoka Y, Strickland CD, et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999; 401: 390-394
5. Huard J, Roy R, Bouchard JP, et al. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant Proc 1992; 24: 3049-3051
6. Miller RG, Sharma KR, Pavlath GK, et al. Myoblast implantation in Duchenne muscular dystrophy: The San Francisco Study. Muscle Nerve 1997; 20: 469-478
7. Morandi L, Bernasconi P, Gebbia M, et al. Lack of mRNA and dystrophin expression in DMD patients three months after myoblast transfer. Neuromuscul Disord 1995; 5: 291-295
8. Tremblay JP, Malouin F, Roy R, et al. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 1993; 2: 99-112
9. Quenneville SP, Tremblay JP. Ex vivo modification of cells to induce a muscle-based expression. Curr Gene Ther 2006; 6: 625-632
10. Vilquin JT. Myoblast transplantation: Clinical trials and perspectives. Mini-review. Acta Myol 2005; 24: 119-127
11. Skuk D, Tremblay JP. Cell therapies for inherited myopathies. Curr Opin Rheumatol 2003; 15: 723-729
12. Beauchamp JR, Morgan JE, Pagel CN, et al. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J Cell Biol 1999; 144: 1113-1122
13. Morgan JE, Coulton GR, Partridge TA. Muscle precursor cells invade and repopulate freeze-killed muscles. J Muscle Res Cell Motil 1987; 8: 386-396
14. Watt DJ, Morgan JE, Clifford MA, et al. The movement of muscle precursor cells between adjacent regenerating muscles in the mouse. Anat Embryol (Berl) 1987; 175: 527-536
15. Skuk D, Goulet M, Roy B, et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006; 65: 371-386
16. Skuk D, Goulet M, Roy B, et al. First test of a ''high-density injection'' protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 2007; 17: 38-46
17. Cantini M, Massimino ML, Bruson A, et al. Macrophages regulate proliferation and differentiation of satellite cells. Biochem Biophys Res Commun 1994; 202: 1688-1696
18. Cantini M, Giurisato E, Radu C, et al. Macrophage-secreted myogenic factors: A promising tool for greatly enhancing the proliferative capacity of myoblasts in vitro and in vivo. Neurol Sci 2002; 23: 189-194
19. Sonnet C, Lafuste P, Arnold L, et al. Human macrophages rescue myoblasts and myotubes from apoptosis through a set of adhesion molecular systems. J Cell Sci 2006; 119: 2497-2507
20. Chazaud B, Sonnet C, Lafuste P, et al. Satellite cells attract monocytes and use macrophages as a support to escape apoptosis and enhance muscle growth. J Cell Biol 2003; 163: 1133-1143
21. Sampaolesi M, Blot S, D'Antona G, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006; 30: 574-579
22. Dellavalle A, Sampaolesi M, Tonlorenzi R, et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 2007; 9: 255-267
23. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309: 314-317
24. Mouly V, Aamiri A, Bigot A, et al. The mitotic clock in skeletal muscle regeneration, disease and cell mediated gene therapy. Acta Physiol Scand 2005; 184: 13-15
25. Machida S, Spangenburg EE, Booth FW. Primary rat muscle progenitor cells have decreased proliferation and myotubes formation during passages. Cell Prolif 2004; 37: 267-277
26. Pouzet B, Vilquin JT, Hagege AA, et al. Factors affecting functional outcome after autologous skeletal myoblast transplantation. Ann Thorac Surg 2001; 71: 844-850